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Neurofibromatosis type 1 (NF1) is a common auto-
somal-dominant disorder associated with attention
deficits and learning disabilities. The primary known
function of neurofibromin, encoded by the NF1
gene, is to downregulate Ras activity. We show that
nf1-deficient zebrafish exhibit learning and memory
deficits and that acute pharmacological inhibition
of downstream targets of Ras (MAPK and PI3K)
restores memory consolidation and recall but
not learning. Conversely, acute pharmacological
enhancement of cAMP signaling restores learning
but not memory. Our data provide compelling evi-
dence that neurofibromin regulates learning and
memory by distinct molecular pathways in verte-
brates and that deficits produced by genetic loss of
function are reversible. These findings support the
investigation of cAMP signaling enhancers as a com-
panion therapy to Ras inhibition in the treatment of
cognitive dysfunction in NF1.INTRODUCTION
Neurofibromatosis type 1 (NF1) is associated with a broad range
of clinical characteristics, including a predisposition to develop
benign and malignant tumors, pigmentation defects, and cogni-
tive deficits (Cichowski and Jacks, 2001). As many as 50%–70%
of children with NF1 exhibit attention deficits and learning
disabilities that contribute to scholastic underachievement
and impaired social development (Hyman et al., 2005, 2006; Lev-
ine et al., 2006). Genetic and pharmacological experiments
performed in mice and Drosophila support a role for the Ras-
GTPase activating domain (GRD), which functions to downregu-
late Ras activity in protein-synthesis-dependent memory (Costa
et al., 2002; Cui et al., 2008; Guilding et al., 2007; Ho et al., 2007;
Li et al., 2005; Silva et al., 1997). However, cognitive dysfunctionCell Rein NF1 has been linked to mutations throughout the NF1 gene
that do not cluster in the region encoding the GRD, leading to
the proposal that neurofibromin serves additional cellular func-
tions (Fahsold et al., 2000). Studies performed inDrosophila sug-
gest that neurofibromin can also stimulate adenylyl cyclase (AC),
cAMP production, and PKA to promote learning and memory
(Guo et al., 2000; Hannan et al., 2006; The et al., 1997; Tong
et al., 2002). Nf1-deficient Drosophila brains show reduced
cAMP levels, and expression of a C-terminal neurofibromin frag-
ment lacking the GRD is sufficient to rescue learning (Ho et al.,
2007; Tong et al., 2002). Similarly, brains of Nf1+/ mice exhibit
reduced cAMP levels (Brown et al., 2010, 2012; Hegedus
et al., 2007) and cAMP regulation of dopaminergic function in
the hippocampus is disrupted (Diggs-Andrews et al., 2013).
The mechanism by which neurofibromin regulates AC remains
controversial, and both Ras-dependent and Ras-independent
pathways have been suggested (Guo et al., 1997; Hannan
et al., 2006; Tong et al., 2002). Studies in Drosophila models of
NF1 further argue that the resulting elevation in Ras activity,
mediated through the upstream activation of neuronal dAlk, is
responsible for observed decreases in cAMP signaling (Gouzi
et al., 2011; Walker et al., 2006, 2013). Neurofibromin is also
known to modulate both neural and glial development from
neuroglial progenitors, and both Ras and cAMP have been impli-
cated (Hegedus et al., 2007). Recent studies suggest that phar-
macological activation of the cAMP pathway may enhance
cognition in murine models (Jayachandran et al., 2014; Peng
et al., 2014; Richter et al., 2013). However, it remains unclear
whether NF1-dependent cAMP signaling is critical for learning
or memory in vertebrates. Furthermore, the contributions of
developmental and structural abnormalities to learning and
memory deficits in NF1 have not yet been clearly defined (Arm-
strong et al., 2012; Karlsgodt et al., 2012; Shilyansky et al., 2010).RESULTS AND DISCUSSION
We utilized a zebrafish model of NF1 that harbors null alleles in
the NF1 orthologs nf1a and nf1b (Shin et al., 2012) to evaluate
molecular signaling pathways that control NF1-dependentports 8, 1265–1270, September 11, 2014 ª2014 The Authors 1265
Figure 1. nf1 Mutant Larvae Exhibit Reduced Memory Recall
(A) Schematic representation of the visual memory assay. ISI, interstimulus interval.
(B–F) Mean O-bend latency (B) or latency change (C–F) 1 hr after spaced training (test) versus untrained controls (n = 26–130 O-bend maneuvers per genotype/
treatment). #p < 0.001 versus wild-type untreated (C) or DMSO-treated (B and D–F) larvae. *p < 0.01, **p < 0.001 versus same genotype, DMSO-treated larvae.
One-way ANOVA. Error bars denote SEM.
See also Figures S2 and S3.learning and memory in vertebrates. Larval zebrafish show a
remarkable capacity for behavioral plasticity in response to
visual and acoustic stimuli, including habituation (Roberts
et al., 2013; Wolman et al., 2011), as evidenced by a progressive
decline in responsiveness to repeated, inconsequential stimuli
(Thompson and Spencer, 1966). The duration of habituated
behavior provides a metric for nonassociative learning (short-
term habituation) and memory formation and recall (longer-
term, protein-synthesis-dependent habituation). Importantly,
habituation reflects a highly conserved form of attention-based
learning and memory that is similar to the type of cognition
impairment found in NF1 children (Hyman et al., 2005; Isenberg
et al., 2013; Levine et al., 2006). We tested 5-day-old larvae for
protein-synthesis-dependent visual habituation to evaluate
memory formation and recall. After a period of light adaptation,
exposing the larvae to a sudden absence of light, termed a
dark flash, elicited a highly stereotyped yet habituatable reorien-
tation maneuver known as an O-bend (Movie S1; Burgess and
Granato, 2007a). Delivering repetitive dark flashes through a
spaced training paradigm elicited protein-synthesis-dependent
memory formation (Figures 1A and 1B). One hour after training,
wild-type larvae showed a near doubling in the latency time
period before initiating an O-bend compared with responses
prior to training (Figure 1B). Treatment with the protein synthesis1266 Cell Reports 8, 1265–1270, September 11, 2014 ª2014 The Auinhibitor cycloheximide (CHX, 10 mM) abolished this increase
(Figure 1B), consistent with a requirement for protein synthesis
(Beck and Rankin, 1995; Davis and Squire, 1984). Larvae null
for nf1a or nf1b showed impaired memory (Figure 1C). This
memory deficit is consistent with cognitive impairment observed
in NF1 patients and in other animal models of NF1, and supports
the use of nf1mutant zebrafish to probe themechanisms of NF1-
dependent cognition.
Memory impairment in Drosophila and mouse NF1 models is
due at least in part to elevated Ras signaling (Costa et al.,
2002; Cui et al., 2008; Hannan et al., 2006; Li et al., 2005). Since
nf1 mutant larvae also show increased Ras activity (Shin et al.,
2012), we asked whether acute pharmacological inhibition of
the Ras effectors MAPK and PI3K could improve memory recall
in nf1 mutants. Small molecules readily cross the developing
blood-brain barrier of larval zebrafish until at least 8 days
of age (Fleming et al., 2013), facilitating pharmacogenetic
approaches for identifying signaling pathways that underlie bio-
logical processes and screening of potential therapeutics for
neuropsychiatric disorders such as NF1. We treated wild-type,
nf1a+/; nf1b/, and nf1a/; nf1b/ larvae with inhibitors of
MAPK (U0126) or PI3K (wortmannin, BKM120) for 30 min before
and throughout training and testing for memory recall. Each
compound improved memory recall in nf1 mutant larvae in athors
Figure 2. cAMP Signaling Mediates nf1-Dependent Visual Learning
(A) Schematic representation of the visual learning assay.
(B–E) Mean percentage of habituation to repeated dark-flash stimulation (n = 3
groups of 15–20 larvae for all genotype/treatment groups). #p < 0.001 versus
DMSO-treated wild-type larvae. *p < 0.01, **p < 0.001 versus DMSO-treated
nf1a/; nf1b/ larvae. One-way ANOVA. Error bars denote SEM.
See also Figures S1 and S3.dose-dependent manner (Figures 1D–1F). Treatment with 1 mM
wortmannin restored memory to wild-type levels, and 1 mM
U0126 or 3 mM BKM120 yielded significant memory improve-
ment. Although each of these Ras pathway antagonists exhibits
known off-target effects, their different selectivity profiles (Bain
et al., 2007; Liao and Laufs, 2005; Maira et al., 2012) suggest
that nonspecific effects are unlikely to underlie the observed in-
crease in memory recall. Therefore, these results support a
conserved function for the neurofibromin GRD domain in regula-
tion of memory formation through the Ras/MAPK/PI3K signaling
pathway.Cell ReLearning (the acquisition of information) is critical for establish-
ing memory. We evaluated learning by exposing larvae to dark-
flash stimuli delivered at 3 s interstimulus intervals (ISIs) and
measuring short-term habituation, as indicated by a reduction
in the probability of initiating an O-bend response (Figure 2A).
nf1a/; nf1b/ larvae showedmarkedly reduced short-term vi-
sual (Figure 2B) and acoustic (Figures S1A and S1B; Shin et al.,
2012) habituation compared with wild-type controls. Notably,
nf1a/; nf1b/ larvae showed some capacity for learning,
which likely accounts for their potential to form memories in
the presence of Ras pathway inhibitors (Figures 1D–1F). Larvae
with at least one wild-type allele of either nf1a or nf1b did not
show a learning deficit, despite dramatic memory deficits (Fig-
ure 1C; M.A.W. and E.D.d.G., unpublished data; Shin et al.,
2012). It is possible that our nonassociative habituation assay
lacks the necessary sensitivity to detect relatively subtle learning
deficiencies in larvae with these genotypes. Attenuating Ras
signaling by acute pharmacological inhibition of MAPK (U0126)
or PI3K (wortmannin) failed to improve the learning deficit of
nf1a/; nf1b/ larvae (Figures 2B and S1B), suggesting that
a distinct pathway mediates NF1-dependent learning.
Whole larval lysates revealed reduced cAMP levels in nf1a/;
nf1b/ mutants compared with wild-type controls (nf1a/;
nf1b/: 33 fmol ± SEM 2.3 versus wild-type: 79 fmol ± SEM
7.8, p < 0.001). To determine whether reduced cAMP signaling
contributed to the learning deficits in nf1a/; nf1b/ mutants,
we tested whether enhancing cAMP signaling by acute pharma-
cological inhibition of phosphodiesterase 4 (PDE4) or stimulation
of PKA could improve learning. Inhibition of PDE4 by rolipram or
roflumilast, or PKA stimulation by 8-Br-cAMP improved learning
behavior in nf1a/; nf1b/ mutants in response to both repet-
itive visual (Figures 2C–2E) and acoustic (Figures S1C and S1D)
stimuli. Treatment with at least 10 mM rolipram, 0.1 mM roflumi-
last, or 3 mM 8-Br-cAMP improved habituation to wild-type
levels. These results provide evidence that cAMP signaling reg-
ulates NF1-dependent learning in a vertebrate system.
We next askedwhether cAMP signaling regulates NF1-depen-
dent memory in addition to learning. We tested nf1a/; nf1b/
larvae, which show reduced learning and a failure to recall
memory, and nf1a+/; nf1b/ larvae, which learn normally but
fail to formmemory, and compared themwith wild-type controls.
Treatment with 10 mM 8-Br-cAMP, a sufficient dose to restore
learning in nf1a/; nf1b/ larvae (Figures 2E and S1D), failed
to improve memory recall in either nf1a+/; nf1b/ or nf1a/;
nf1b/ larvae (Figure S2). These results suggest that cAMP
signaling regulates NF1-dependent learning but not memory.
Moreover, these results indicate that the memory defects in
nf1a/; nf1b/ mutants are not simply attributable to their
learning deficit. These data strongly imply that molecularly
distinct pathways that control learning and memory are affected
in NF1.
Learned behavior requires consolidation to form stable mem-
ory. Despite consensus that defective neurofibromin function
can result in learning and memory impairments, whether
impaired consolidation contributes to memory deficits remains
unclear. nf1a+/; nf1b/ larvae learn normally (M.A.W. and
E.D.d.G., unpublished data; Shin et al., 2012) but show reduced
memory recall (Figure 1C). Therefore, we askedwhether reducedports 8, 1265–1270, September 11, 2014 ª2014 The Authors 1267
Figure 3. Inhibition of Ras Signaling Improves Memory Consolida-
tion Deficits in nf1 Mutants
(A) Schematic representation of visual memory consolidation measurement.
(B) Mean O-bend latency change comparing responses to dark-flash stimuli
1–5 of sessions 2–4 versus stimuli 1–5 of session 1 (n = 30–139 O-bend
maneuvers per genotype/treatment). #p < 0.001 versus DMSO-treated wild-
type larvae. *p < 0.01, **p < 0.001 versus DMSO-treated nf1a+/; nf1b/
larvae. One-way ANOVA. Error bars denote SEM.
See also Figure S3.
Figure 4. Effects of NF1 Loss of Function on the Ras and cAMP
Pathways
The genotypes of the zebrafish nf1 larvae that exhibited significant memory or
learning deficits are shown. The pharmacological agents (italicized) that
were used to improve memory or learning in these genotypes, as well as the
molecular targets of the agents, are indicated. LOF, loss of function.memory was due to a consolidation deficit. We determined
memory consolidation by calculating the difference between
the mean O-bend latency in response to the first five dark-flash
stimuli of training session 1 and subsequent training sessions
(Figure 3A). Long ISIs between training sessions promote mem-
ory consolidation, and therefore spaced training paradigms
elicit more stable memory than do massed training paradigms
(Beck and Rankin, 1997; Ebbinghaus, 1885). After each session,
nf1a+/; nf1b/ larvae showed reduced consolidation com-
pared with wild-type larvae (Figure 3B), suggesting that the
memory-recall deficit observed in nf1a+/; nf1b/ larvae (Fig-
ure 1C) may be due to a defect in memory consolidation.
To determine the contribution of cAMP and Ras signaling
to NF1-dependent memory consolidation, we attempted to
improve consolidation in nf1a+/; nf1b/ larvae by pharmaco-
logically enhancing cAMP or attenuating Ras. Enhancing cAMP
in nf1a+/; nf1b/ larvae by treatment with 10 mM 8-Br-cAMP
did not increase consolidation (Figure 3B). Pharmacological inhi-
bition of MAPK (1 mM U0126) or PI3K (1 mM wortmannin)
improved memory consolidation in nf1a+/; nf1b/ larvae to
levels indistinguishable from those observed in DMSO-treated
wild-type larvae (Figure 3B). These results reveal that deficits in
memory consolidation contribute to the etiology of memory
dysfunction in NF1 and support a specific role for Ras signaling
in mediating NF1-dependent memory formation.
Larvae deficient for nf1 exhibit learning and memory deficits
with characteristics reminiscent of those seen in human NF11268 Cell Reports 8, 1265–1270, September 11, 2014 ª2014 The Aupatients. We obtained strong evidence in a vertebrate system
that NF1 affects at least two distinct signaling pathways that
independently modulate learning and memory (Figure 4). A
detailed understanding of the structure-function relationship
among NF1 mutations, Ras and cAMP signaling, and pheno-
types will allow for tailored and personalized therapies for cogni-
tive defects in affected patients. It will also be interesting to
determine whether the dynamic regulation of Ras or cAMP
signaling in distinct areas of the brain correlates with unique
behavioral outcomes. The fact that we observed robust improve-
ments in learning and memory in our experiments even though
we used only short-term treatments is encouraging for potential
clinical application, and suggests that cognitive defects in this
model are not developmental or irreversible. It will be exciting
to determine whether these models can be validated in higher
vertebrates and whether combination therapy with Ras and
cAMP pathway effectors can improve the condition of some
NF1 patients.
EXPERIMENTAL PROCEDURES
Generation and Maintenance of Zebrafish
The zebrafish (Danio rerio) larvae used in this study were generated from
crosses of adults carrying the nf1aD5 and nf1b+10 mutant alleles (Shin et al.,
2012). Embryos were raised at 28C in a 14 hr/10 hr light/dark cycle as
previously described (Burgess and Granato, 2007a) and all behavioral exper-
iments were conducted with 5 days postfertilization (dpf) larvae. For visual
behavioral experiments, larvae were PCR genotyped by clipping a small region
of the caudal fin at 3 dpf and genotyping as described previously (Shin et al.,
2012). Larvae tested for acoustic habituation were tested individually in a 43 4
grid and genotyped after testing. All animal protocols were approved by the
University of Pennsylvania Institutional Animal Care and Use Committee.thors
Behavioral Assays and Analysis
Dark-flash-induced O-bend responses were elicited, recorded, and mea-
sured as previously described (Burgess and Granato, 2007a; Wolman
et al., 2011). Larvae were trained and tested at a density of 15 larvae per
9 ml E3 in 6 cm Petri dishes and kept in the dishes during training or testing.
To elicit memory formation, larvae were exposed to a training paradigm
comprised of four 30 min training sessions, each consisting of exposure to
a 1 s dark flash delivered every 15 s. Training sessions were separated by
10 min ISIs. After the fourth session and a 1 hr ISI, larvae were exposed to
ten dark flashes with 1 min ISIs to evaluate memory recall. To calculate
memory recall, the average latency to initiate an O-bend in untrained larvae
was subtracted from the latency to initiate an O-bend in trained larvae.
Memory consolidation was calculated by subtracting the average latency
to initiate an O-bend in response to dark-flash stimuli 1–5 of training session
1 from the latency to initiate an O-bend in response to dark flashes 1–5 of
sessions 2–4.
To measure visual short-term habituation, a series of 40 1 s dark flashes
were delivered. Stimuli 1–10 were delivered with 30 s ISIs and stimuli 11–40
were delivered with 3 s ISIs. The percentage of habituation was calculated
by dividing the mean O-bend responsiveness to stimuli 31–40 by the mean
O-bend responsiveness to stimuli 1–10, subtracting this value from 1, and
multiplying by 100. An acoustic short-term habituation assay was performed
as previously described (Wolman et al., 2011).
Pharmacology
All compounds were added to the larval media 30 min before and throughout
the training and testing paradigm. Cycloheximide (C4859; Sigma-Aldrich),
U0126 (9903, Cell Signaling Technology), wortmannin (9951; Cell Signaling
Technology), BKM120 (S2247; Selleck Chemicals), rolipram (R6520; Sigma-
Aldrich), roflumilast (S2131, Selleck Chemicals), and 8-Br-cAMP (B007;
BIOLOG Life Science Institute) were dissolved in 100% DMSO and adminis-
tered in a final concentration of 1% DMSO. Doses of each compound were
prescreened for potential effects on baseline O-bend responsiveness to visual
stimuli and short-latency C-bend responsiveness to acoustic stimuli. The
defined, stereotyped kinematic parameters of both larval maneuvers were
also examined (Burgess and Granato, 2007a, 2007b). Selected doses did
not change baseline behavior responsiveness or kinematic performance after
30 min or 4 hr of incubation. Immunohistochemistry with anti-phospho-ERK
(4377; Cell Signaling Technology) and anti-phospho-(Ser/Thr) PKA substrate
(9621; Cell Signaling Technology) was performed on paraffin-embedded larval
tissue after fixation in 4% paraformaldehyde, dehydration, and sectioning at
8 mM thickness in order to demonstrate the pathway specificity of the pharma-
cologic inhibitors (Figure S3).
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